Crohn's Disease Diagnosed at 60: What Changes

Yes, Crohn's disease can be diagnosed for the first time at 60, and at 70 or 80 too. Roughly one in four new inflammatory bowel disease diagnoses in a Swedish national study was in someone aged 60 or over (Everhov 2018). Crohn's that starts later tends to sit in the colon and is less often fistulising, but it is not reliably mild, and the trade-offs of treatment and surgery shift with age.

If you, or a parent, have just been told "Crohn's" at an age when most people associate the word with twenty-somethings, this article is for you. Much of what you will read online is written for younger patients, and some of what is written for older ones repeats numbers that do not hold up when you trace them back. We traced them. Where the evidence is thin or contradictory, we say so.

Can you get Crohn's disease at 60, or even in your 70s?

Yes. Crohn's disease can start at any age, and a meaningful share of diagnoses happen after 60. A 2021 American Gastroenterological Association (AGA) expert review puts it at up to 15% of new IBD in North America and Asia, and estimates that about 1 in 160 older adults lives with IBD (Ananthakrishnan 2021).

The best population numbers come from Sweden. Of 27,834 people newly diagnosed with any form of IBD between 2006 and 2013, 6,443 (23%) were 60 or older. In that age group the rate of new Crohn's disease was 10 per 100,000 person-years, about half the rate of new ulcerative colitis (Everhov 2018). So Crohn's starting after 60 is uncommon in absolute terms but far from a medical curiosity.

How old is "old" here? In a French population registry of 367 people diagnosed with Crohn's after 60, the median age at diagnosis was 70, and the middle half of patients were diagnosed between 65 and 76 (Charpentier 2014). That means a quarter were older than 76 when they were told.

That matches what people describe online. In an r/CrohnsDisease thread titled "Diagnosed at age 60! Am I really the oldest person here?", the poster felt alone because the forum skews young, and the replies filled with diagnoses at 63 and 64, a relative diagnosed near 70 and someone who met a woman diagnosed at 75. In a separate thread about Crohn's in very old age, one reply mentions a grandmother diagnosed at 80. Reddit's audience is younger than the people this happens to, so a lot of the online conversation about late diagnosis comes from adult children posting on a parent's behalf.

What counts as late-onset Crohn's disease?

There is no single cut-off. Most recent research and the AGA review use 60 and over as "elderly-onset". Older studies used 40 or 50, which matters because a finding about "older" patients may have been measured in people who were 41.

This is not pedantry. Some of the most quoted comparisons use much younger thresholds than the word "elderly" suggests:

• A large hospital series of 552 patients compared people diagnosed at 40 or older with those diagnosed under 20 (Polito 1996).
• A 1998 comparison study defined "elderly" as symptoms starting at 40 or older (Wagtmans 1998).
• A 2016 meta-analysis pooled 43 studies using 50 as the threshold (Ananthakrishnan 2016).
• The Swedish and French registries used 60 (Everhov 2018; Charpentier 2014).

That hospital series also describes Crohn's as having a bimodal age pattern, with peaks around 20 and 50 in its cohort (Polito 1996). When a website says "a second peak in your 60s", it is generalising from data like this, and the exact age of the second peak varies between populations.

When we quote a study below, we name the age cut-off it used.

Why would Crohn's disease start later in life?

No one can tell an individual why their Crohn's began at 60, and anyone who claims to is guessing. What research shows is that inherited risk appears to play a smaller part when Crohn's starts late, and some environmental exposures, antibiotics in particular, are linked with IBD at every age.

Genes seem to matter less

In a North American cohort of 697 people with Crohn's, those carrying the most known IBD risk variants were diagnosed about five years earlier than those carrying the fewest, and were more likely to have disease in the ileum, the last part of the small bowel (Ananthakrishnan 2014). The authors also stressed that known risk genes explain only a fraction of how Crohn's behaves.

Family history points the same way. In the hospital series, 13.6% of people diagnosed at 40 or older had a relative with Crohn's, against 29.9% of those diagnosed before 20 (Polito 1996). In the 1998 comparison the figures were 3.1% and 12% (Wagtmans 1998). A small 1986 comparison of 24 patients aged 64 to 85 found no family history of IBD at all in the older group (Harper 1986).

So if your siblings are asking whether they should worry, the honest answer is that a late-onset diagnosis carries less evidence of strong family clustering than a childhood one. It does not mean zero risk.

Antibiotics and diet: associations, not causes

A Danish nationwide study of more than six million people found antibiotic use was linked with a higher risk of later IBD at every age. For people aged 60 and over, the incidence rate ratio was 1.47, the risk was highest one to two years after a course, and it rose with the number of courses (Faye 2023). This is an observational link. It cannot separate the antibiotic from the infection it was treating, or from early, undiagnosed bowel symptoms that led to the prescription in the first place.

Diet has a weaker and narrower signal. In two Swedish cohorts of 83,147 adults, those in the top quarter of a healthful plant-based diet score had about half the risk of older-onset Crohn's (hazard ratio 0.52) compared with the bottom quarter. Two other diet scores showed no clear link, and none of the four scores was associated with ulcerative colitis (Khalili 2023). The study counted 164 cases of Crohn's, so the estimates are not precise.

Neither finding means a past antibiotic course or a past diet "caused" your Crohn's. They are clues for researchers, not verdicts for patients.

What are the symptoms of Crohn's disease in older adults?

The symptoms are the same as at any age: diarrhoea, abdominal pain, weight loss, tiredness and sometimes rectal bleeding. Comparison studies suggest older patients report abdominal pain somewhat less often and rectal bleeding more often, which fits the tendency for late-onset Crohn's to sit in the colon rather than the small bowel.

In the 1998 comparison, abdominal pain or cramps were reported by 59% of the older group and 71% of the younger group, while diarrhoea, rectal blood loss and weight loss were similarly common in both (Wagtmans 1998). The small 1986 series found older patients had more visible blood in the stool, less pain and less often a palpable abdominal mass, and concluded there were no distinguishing features that made the diagnosis easy in older people (Harper 1986).

That last point matters. Less pain is not reassuring; it may mean the disease is noticed later. And every one of these symptoms overlaps with conditions that become more common after 60, including bowel cancer. That is why the AGA review says IBD should be considered in any older person with diarrhoea, rectal bleeding, urgency, abdominal pain or weight loss (Ananthakrishnan 2021), and why those same symptoms should never be self-diagnosed as Crohn's.

Does late-onset Crohn's disease look different?

Usually, yes. Crohn's diagnosed later in life is more likely to affect the colon only and less likely to involve fistulas or the area around the anus. Where studies disagree is how often it narrows the bowel into strictures, and how large the colonic share really is.

The pooled evidence first. A meta-analysis of 43 studies found older-onset Crohn's patients (diagnosed at 50 or later) were about two and a half times as likely to have colonic disease (odds ratio 2.56) and slightly more likely to have purely inflammatory disease (odds ratio 1.19), and less likely to have penetrating or perianal disease (Ananthakrishnan 2016).

Now the individual studies, which do not agree on the details:

What this means in practice: an older person with Crohn's colitis can look, on a colonoscopy, a lot like other colitis types, which feeds directly into the next question.

Why was it missed for so long? Tracing the "60% misdiagnosed" figure

Older people with Crohn's are more often given a wrong first diagnosis, but the dramatic figures circulating online, up to 60% misdiagnosed and up to six years of delay, do not match the study they are attributed to. Modern data suggest older age is not, on its own, a driver of long diagnostic delay.

Several patient-facing pages ranking for this topic state that up to 60% of older patients are initially misdiagnosed, compared with 15% of younger patients, with delays of up to six years. We followed the trail. A 2016 review makes this statement and cites a 1998 comparison study for it (Nimmons 2016). That study's abstract reports:

• Crohn's was the correct first diagnosis in 49% of the older group and 61% of the younger group. Put the other way, roughly 51% versus 39% received a different diagnosis first.
• Diverticulitis (7.1% vs 0%) and cancer (6.1% vs 0.9%) were more common wrong first diagnoses in the older group.
• The time to diagnosis was shorter in the older group: 1.8 years versus 2.7 years.
• "Older" meant symptoms starting at 40 or above.

(Wagtmans 1998)

So the cited source supports "wrong first diagnoses are more common with age", but not the 60%-versus-15% split, and it directly contradicts "older people wait longer". We did not find the six-year figure in its abstract. The full paper may contain other numbers; we could not access it, so we cannot rule that out. What we can say is that the abstract's headline findings run the opposite way to how they are being retold.

Other evidence is mixed. The small 1986 series of 24 patients did find a longer delay in the older group (Harper 1986). But in the Swiss IBD cohort of 932 people with Crohn's, it was being under 40 at diagnosis that predicted a long delay of more than two years (odds ratio 2.15), along with ileal disease (Vavricka 2012).

If your diagnosis did take years, it was probably not because of a single error. Symptoms in older adults are routinely, and reasonably, investigated first for more common conditions, and Crohn's can hide behind them. One person in the elderly Crohn's thread described being diagnosed at 61 after earlier surgery on part of the colon for diverticulitis with a fistula. Another thread on late diagnoses is full of people in their 40s and 50s whose earlier symptoms had been called IBS, stress or diet.

What can be mistaken for Crohn's disease after 60?

The main look-alikes are diverticular disease and diverticular colitis, ischaemic colitis, microscopic colitis, drug-induced bowel inflammation (especially from anti-inflammatory painkillers), infections, radiation damage and bowel cancer. The AGA review lists all of these as more likely after 60 than before 40 (Ananthakrishnan 2021).

We cover these look-alikes in detail, with a comparison table, in our post on late-onset ulcerative colitis; the list is the same for Crohn's colitis. Two points are specific to Crohn's:

• Diverticular disease can be confused with Crohn's, or coexist with it. The AGA review advises that when an older person has patchy left-sided colitis alongside diverticula, segmental colitis associated with diverticulosis should be considered as well as Crohn's disease or unclassified IBD (Ananthakrishnan 2021). Abscesses and fistulas can occur in both.
• Crohn's is sometimes first recognised at an operation. In the 1998 comparison, 25% of the older group got the Crohn's diagnosis at their first operation, against 12% of the younger group (Wagtmans 1998).

How is Crohn's disease diagnosed in an older adult?

The same way as at any age, with a few extra checks: blood tests, stool tests including for C. difficile, often a CT scan if pain is prominent, and a colonoscopy with biopsies as the cornerstone. Imaging of the small bowel is usually added to map how much is involved.

The AGA review's suggested first steps are a full blood count, albumin, ferritin and C-reactive protein, liver and kidney tests (partly as a baseline before any medication), and stool testing for C. difficile in every new presentation of diarrhoea regardless of recent antibiotic use. It suggests CT for older people with acute symptoms, especially when pain dominates, because it can also pick up ischaemia or diverticular disease. Faecal calprotectin can help decide who needs a colonoscopy most urgently, and colonoscopy with biopsies "remains a cornerstone of diagnosis" (Ananthakrishnan 2021).

The review also notes that procedural and anaesthetic risks are weighed more carefully in older people with other illnesses. If small bowel imaging is planned, our guide to what to expect during an MRI enterography walks through the day.

Does late-onset Crohn's get worse with age, or is it milder?

On paper it starts out milder, but in practice it is not benign. Location rarely spreads, and fistulas are less common, yet about one in three people diagnosed after 60 in the best population registry had bowel surgery within ten years.

The French registry is the clearest long-term picture of Crohn's diagnosed after 60 (Charpentier 2014):

• Over a median six years of follow-up, the disease spread to new areas in only 8% and developed a complicated behaviour (strictures or fistulas) in 9%.
• By ten years, 47% had received steroids, 27% immunosuppressants and 9% anti-TNF drugs.
• 18% had surgery within the first year and 32% within ten years.
• Having complicated disease at diagnosis was linked with a higher surgery risk (hazard ratio 2.6).

The authors concluded the clinical course is "mild". We would put it more carefully. Little spread and few new complications is good news, but a one-in-five chance of an operation in the first year after diagnosis is not what most people mean by mild. Part of that early surgery may reflect people who were diagnosed at, or because of, an operation, which we could not check from the abstract.

The pooled data say the same thing. Older-onset Crohn's patients received immunomodulators and biologics far less often (odds ratios 0.44 and 0.34), yet their need for surgery was similar to younger patients, with a pooled odds ratio of 0.70 whose confidence interval (0.40 to 1.22) spans no difference (Ananthakrishnan 2016). The authors could not tell whether this reflects a less benign disease, doctors' reluctance to use stronger drugs, or both. The Swedish registry reached a similar conclusion: older patients used fewer biologics and immunomodulators and more steroids, had more IBD-related hospital admissions and more bowel surgery (13% at five years versus 10% in younger adults), and the authors wrote that the treatment gap was "not necessarily because of a milder course" (Everhov 2018).

What clearly does get worse with age is the cost of a bad flare. The AGA review states that elderly patients are more likely to die of Crohn's disease, at 33 per 10,000 person-years, than middle-aged (5.6) or young patients (1) (Ananthakrishnan 2021). The review gives these figures in a single sentence without describing how a death was attributed to Crohn's, so treat them as a broad signal that severe disease is more dangerous later in life rather than as a precise risk.

Is treatment for late-onset Crohn's disease different?

The medicines are the same; the weighing is different. Expert guidance says steroids should not be used for maintenance, favours treatments with lower infection and cancer risk where they suit the disease, and bases decisions on frailty and other illnesses as well as age. Under-treatment is its own risk.

We cover the general age-related treatment trade-offs, including frailty and polypharmacy, in the late-onset ulcerative colitis post. Here is what is specific to Crohn's, as set out in the 2021 AGA expert review (Ananthakrishnan 2021):

• Steroids. Not for maintenance at any age. For a flare, budesonide, a steroid that acts mostly in the gut, may be preferred over systemic steroids in Crohn's of the ileum and right colon. Any use of systemic steroids should prompt planning for a steroid-sparing treatment and for bone protection.
• Mesalamine. Widely given to older Crohn's patients because it does not suppress the immune system, but the review notes its benefit in Crohn's is "less well established", with most trials showing no or modest benefit over placebo.
• Thiopurines. Convenient and cheap, but slower and less effective than newer options, and the absolute risks of skin cancers and lymphoma rise with age. The review quotes lymphoproliferative disorders at 5.41 per 1,000 person-years in older thiopurine users against 0.37 in users under 50. It still says thiopurines should not be ruled out on age alone. Our post on Crohn's and night sweats explains the lymphoma numbers and what they mean in absolute terms.
• Methotrexate is described as an attractive option for older people with Crohn's.
• Biologics. The review suggests that, where possible, treatments with lower infection or cancer risk, naming vedolizumab and ustekinumab, may be preferred, while still matching the drug to the disease.

What the studies in older Crohn's patients show

• Anti-TNF drugs. In a single-centre study, 68% of people starting anti-TNF at 65 or older responded at 10 weeks versus 89% of younger patients, but by six months the gap had closed (79.5% vs 82.8%). Severe adverse events were more common in the older group (Lobatón 2015). A multicentre study of 432 IBD patients (Crohn's and ulcerative colitis combined) found one-year remission of 37.7% in those whose disease began after 60 versus 60.8% in under-60s (Amano 2022); it had only 55 elderly-onset patients and three authors declared lecture fees or grants from drug companies.
• Vedolizumab. In a two-country cohort, one-year remission in Crohn's was 40% and 35% in the older and younger groups, a difference the authors found not significant; infections were more common in the older group, 12% against 2% (Cohen 2020). Several authors declared ties to vedolizumab's manufacturer and other companies.
• Ustekinumab versus anti-TNF. A 2025 multicentre study of 207 Crohn's patients aged 60 or over found no difference in serious infections (3.1% vs 2.8%, after statistical adjustment) or six-month remission (55.9% vs 52.4%) between ustekinumab and anti-TNF drugs (Gebeyehu 2025). That is a useful counterweight to the assumption that one class is clearly safer at this age, although six months is short follow-up.
• Early combination therapy. In a post hoc analysis of the REACT trial, 311 patients were 60 or over. Over two years, Crohn's complications occurred in 6.4% of older patients given early combined immunosuppression versus 14.5% with conventional step-up care (Singh 2019). The confidence interval for the older group's hazard ratio (0.31 to 1.51) still spans no effect, so this subgroup cannot prove a benefit on its own; the authors' point is that older patients did not do worse than younger ones. This analysis was publicly and society funded, though several authors declared drug-company ties.

Frailty matters more than the number on the birth certificate. In a cohort of 11,001 IBD patients, 19% of frail people developed an infection in the year after starting anti-TNF treatment, against 9% of fit people, and frailty doubled the odds after adjusting for age and other illnesses (Kochar 2020). If you read about drug choices for your own situation, the question to have answered is less "am I too old?" and more "how robust am I, and what else am I living with?". Never stop or change a medicine on the strength of these numbers; any change belongs with your IBD team.

If a biologic is on the table, our guides to your first biologic infusion and why you need blood tests on a biologic cover the practicalities.

Is surgery a reasonable option for Crohn's diagnosed after 60?

Sometimes it is the better option, and sometimes it carries real risk; the difference is usually whether it is planned or an emergency. For short, inflamed disease at the end of the small bowel, a planned resection has been tested head to head against a biologic. Emergency surgery in older adults carries much higher mortality.

The LIR!C trial randomised adults aged 18 to 80 with limited (40 cm or less), non-stricturing Crohn's of the terminal ileum, in whom conventional treatment had failed, to keyhole resection or infliximab. Quality of life at one year was similar (Ponsioen 2017). Over a median five years of follow-up, 26% of the surgery group later started an anti-TNF drug and none needed a second resection, while 48% of the infliximab group ended up having a resection (Stevens 2020). The trial was not designed around older adults and its abstracts do not break results down by age, so treat it as evidence that surgery is a legitimate first choice for this disease pattern, not as an older-person result.

The other side of the ledger comes from the American College of Surgeons surgical quality database: 15,495 IBD operations. In Crohn's, 30-day mortality was 4.2% in patients aged 65 or over against 0.3% in younger patients, complications were more common (28.0% vs 19.4%), and blood clots after surgery were more likely (Bollegala 2016). The AGA review adds that emergency surgery is independently associated with higher mortality (Ananthakrishnan 2021).

Put together: surgery that is planned, in a well-prepared person, for limited disease, can be a sensible choice at this age. Surgery forced by a complication after months of under-treated disease is the scenario to avoid.

What should happen after a Crohn's diagnosis at 60?

Beyond choosing a treatment, a new diagnosis at this age should trigger a short list of checks: vaccinations, infection screening before immune-suppressing drugs, a review of every medicine you take, bone health if steroids are used, and a named person coordinating care. The AGA review recommends most of these explicitly (Ananthakrishnan 2021).

Our post on questions to ask your doctor about Crohn's disease covers what to ask in the room. This is the checklist of things to make sure are in motion:

1. Vaccinations, ideally before immunosuppression starts. The review names influenza, pneumococcal and shingles vaccines, and notes they are under-used.
2. Screening before biologics: hepatitis B and latent tuberculosis, the same as at younger ages.
3. A full medication review, ideally with a pharmacist. In one survey cited by the review, 29% of people aged 57 to 85 took at least five prescription drugs. Anti-inflammatory painkillers deserve a specific mention.
4. Bone protection if any prolonged steroid course is planned.
5. Kidney function as a baseline, since mesalamine can rarely cause kidney inflammation and kidney function often declines with age.
6. Ordinary cancer screening for your age, which the review says should continue.
7. Clarity on who coordinates. The review describes care involving the gastroenterologist, primary care (including geriatricians), other specialists, surgeons, nutritionists, pharmacists and, where wanted, family. Someone needs to hold the whole picture. The Reddit thread about an 80-year-old mother choosing between two biologics is a good example of the kind of question that should be settled with a team that knows her other conditions, not by strangers.

If you are the adult child of someone newly diagnosed

Your most useful jobs are practical: help keep a record, help with appointments and medication lists, and push gently for a plan if things are not improving. You do not need to become an expert in Crohn's overnight.

A few things worth knowing:

• Weight loss is not a side note. Older adults lose muscle quickly when they are eating little. If a parent is losing weight, say so to the IBD team and ask whether a dietitian referral is possible. Our post on what to eat during a Crohn's flare covers the evidence on food during active disease.
• Speed matters when things get worse. Because older adults do worse after emergency surgery, a parent who is getting steadily sicker on current treatment should be reviewed promptly rather than left to see if it settles.
• Causes are not knowable. In a thread posted by a family about a father's late-onset ulcerative colitis, a relative was demanding a doctor who would name the cause. No doctor can, and the research above explains why. Energy spent hunting a single cause is better spent on getting the disease controlled.
• Older people often do not volunteer bowel symptoms. In the elderly Crohn's thread, one person recalled realising only years later how much a grandmother with Crohn's had quietly managed alone. Ask directly and without embarrassment.

What to track in the first months after diagnosis

Track a few things consistently rather than everything sporadically: daily stool count and form, any blood, abdominal pain, general well-being, weight once a week, every medicine taken, and any infection or hospital visit. That gives the IBD team a clear before-and-after picture as treatment starts.

The five items in the Harvey-Bradshaw Index, a short Crohn's activity score many clinics use, are a ready-made template: general well-being, abdominal pain, number of liquid or soft stools, abdominal mass and complications. Scoring the same way each week makes trends visible. Our guide to what to track in an IBD symptom diary explains the full set of fields, including a treatment record that is especially useful for someone on several medicines.

For older adults, three extras are worth adding: falls or dizziness, because dehydration from diarrhoea can cause both; any new infection, because infection risk is the main safety concern with immune-suppressing treatment; and whether the person is managing at home as usual, because that change is often what a clinician most needs to hear. If typing is a barrier, Clairop lets you describe a symptom or a meal out loud and produces a one-page GI visit report covering activity score, bowel pattern, medication adherence and labs.

Myths about Crohn's disease diagnosed at 60

Myth: "Crohn's is a young person's disease, so it can't be that." It is more common in younger adults, but nearly a quarter of new IBD diagnoses in Sweden were in people 60 and over (Everhov 2018).

Myth: "Late-onset Crohn's is always mild." It is less often fistulising, but 32% of people diagnosed after 60 in the French registry had surgery within ten years (Charpentier 2014), and older people have higher surgical mortality (Bollegala 2016).

Myth: "Most older patients are misdiagnosed for six years." As traced above, the abstract of the study cited for that claim reports a shorter delay in older patients (Wagtmans 1998), and a large Swiss cohort found younger age predicted long delays (Vavricka 2012).

Myth: "You're too old for biologics." The AGA review says decisions should not rest on chronological age alone and that delaying effective therapy or prolonging steroids out of fear of immune therapy is itself a problem (Ananthakrishnan 2021). The risks are real and higher with frailty, but they are weighed, not assumed.

Myth: "It must be genetic, so my children will get it." Late-onset Crohn's carries less evidence of family clustering than early-onset disease (Polito 1996; Ananthakrishnan 2014). Relatives' risk is not zero, but it is not a sentence either.

When to see a doctor promptly

If you are over 60 and have any of the following, see a doctor promptly, whether or not you already have a Crohn's diagnosis:

• Blood in your stool, or black, tarry stools
• Weight loss you cannot explain
• A change in bowel habit lasting more than a few weeks
• Anaemia found on a blood test
• Symptoms that wake you at night
• A fever, or new pain around the anus with swelling or discharge
• A family history of bowel cancer or IBD

Seek emergency care for severe abdominal pain, repeated vomiting, being unable to pass stool or wind, heavy bleeding, or signs of dehydration such as confusion, dizziness on standing or very little urine. In someone already on immune-suppressing treatment, a fever needs a same-day call to the IBD team or urgent care. These rules exist because Crohn's flares, infections and bowel cancer all share early symptoms at this age, and only tests can tell them apart.

The bottom line

Crohn's disease diagnosed at 60 is not rare, not a mistake, and not automatically mild. It tends to start in the colon, it seldom spreads, and it is less often fistulising than in younger people, but surgery is still common and the margin for error with infections and emergency operations is narrower. The figures you may have read about older patients being misdiagnosed for years are shakier than they look; the more reliable lesson is that wrong first diagnoses are more common with age, and that the longest delays are linked with worse Crohn's outcomes.

The best position to be in is a planned one: a clear diagnosis that maps the disease, a treatment chosen for the disease and for you as a whole person, vaccinations and screening done early, and a simple record of how things are going that your team can act on.